Literature DB >> 3746663

Abnormalities of rat bladder contractility in streptozotocin-induced diabetes mellitus.

P A Longhurst, J A Belis.   

Abstract

Diabetic cystopathy is a common complication of diabetes mellitus, but little is known of the mechanisms responsible for the bladder dysfunction. Therefore, the effect of streptozotocin-induced diabetes on urinary bladder function was investigated. Bladders from 2-month diabetic rats were significantly larger than those from age-matched controls. Protein concentrations in bladder body and base were similar in diabetic and control rats. However, due to the greater bladder body weight in diabetic animals, total protein content of bladder bodies from diabetic rats was significantly greater than those from controls. Contractile responses of strips obtained from bladder body and base to stimulatory agents and nerve stimulation were altered by diabetes. In bladder bodies from diabetic rats, the maximal contractile responses to nerve stimulation, acetylcholine and KCl were reduced compared to controls. In addition there was a decreased sensitivity to acetylcholine and KCl in the diabetics. In contrast, with strips from bladder base there was a decrease in sensitivity to nerve stimulation in the diabetic rats, but no change in sensitivity to norepinephrine, acetylcholine, ATP or KCl. The maximal contraction by bladder base in response to norepinephrine was decreased in diabetic rats, but there was no change in maximal contraction by bladder base in response to norepinephrine was decreased in diabetic rats, but there was no change in maximal response to nerve stimulation, acetylcholine, ATP or KCl. These results indicate that a relatively nonspecific decrease in the responsiveness of bladder body is caused by diabetes, but agonist-specific changes are produced in bladder base.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3746663

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  19 in total

1.  Impaired M3 and enhanced M2 muscarinic receptor contractile function in a streptozotocin model of mouse diabetic urinary bladder.

Authors:  K J Pak; R S Ostrom; M Matsui; F J Ehlert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-27       Impact factor: 3.000

Review 2.  Diabetic bladder dysfunction.

Authors:  Guiming Liu; Firouz Daneshgari
Journal:  Chin Med J (Engl)       Date:  2014       Impact factor: 2.628

Review 3.  Contemporary concepts in the aetiopathogenesis of detrusor underactivity.

Authors:  Nadir I Osman; Christopher R Chapple
Journal:  Nat Rev Urol       Date:  2014-10-21       Impact factor: 14.432

4.  Inhibitory effect of streptozotocin-induced diabetes on non-cholinergic motor transmission in rat detrusor and its prevention by sorbinil.

Authors:  G N Luheshi; M A Zar
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

5.  Early molecular changes associated with streptozotocin-induced diabetic bladder hypertrophy in the rat.

Authors:  H P Koo; R P Santarosa; R Buttyan; R Shabsigh; C A Olsson; S A Kaplan
Journal:  Urol Res       Date:  1993

6.  Nitric oxide-mediated neurotransmission is attenuated in the anococcygeus muscle from diabetic rats.

Authors:  K J Way; J J Reid
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

7.  The effect of streptozotocin-induced diabetes on cholinergic motor transmission in the rat urinary bladder.

Authors:  G N Luheshi; M A Zar
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

Review 8.  Diabetic bladder dysfunction: current translational knowledge.

Authors:  Firouz Daneshgari; Guiming Liu; Lori Birder; Ann T Hanna-Mitchell; Samuel Chacko
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

9.  Effect of diabetes and elevated glucose on nitric oxide-mediated neurotransmission in rat anococcygeus muscle.

Authors:  K J Way; J J Reid
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

Review 10.  Purinergic signalling in the urinary tract in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.